依托咪酯、美托咪酯、曲马多……这些医疗用麻精药品具有毒品属性，千万别滥用！

Core Viewpoint - The Supreme People's Court has proposed strengthening the regulatory framework for medical narcotic drugs in response to rising abuse and trafficking issues, prompting the National Health Commission to take decisive actions to address these problems [1][3]. Group 1: Regulatory Actions - The Supreme People's Court has sent judicial recommendations to the National Health Commission to enhance the regulatory system for medical narcotic drugs [1]. - The National Health Commission is drafting relevant regulations to combat the misuse of narcotic drugs [1]. Group 2: Abuse and Trafficking Issues - Various narcotic drugs, including etomidate, methohexital, tramadol, dextromethorphan, and synthetic cannabinoids, are being abused and sold illegally [1]. - Some hospitals, clinics, and pharmacies have become channels for the illegal distribution of narcotic drugs, with certain medical personnel exploiting their positions for profit [1]. - There is a noted increase in new drug cases as illegal substances are being marketed as alternatives to traditional drugs [1]. Group 3: Public Awareness and Compliance - Patients and their families often resell leftover narcotic drugs due to a lack of understanding of regulations, convenience, or financial reasons, which can lead to legal repercussions [3]. - The Supreme People's Court emphasizes the importance of adhering to medical advice regarding narcotic drugs and properly disposing of any leftover medication to prevent legal issues [3].